Hundreds of sickle cell patients are to benefit from £1.5m technology investment from NHS England
Children, young people, and adults across England suffering from sickle cell disease will soon benefit from better care closer to where they live, following the announcement of a £1.5m investment in 25 red blood cell exchange devices. Funding for the Spectra Optia(R) Apheresis System devices has been distributed ...
Harriet Smith Verena Stocker Antoinette Gawin John Stewart National Programme National Programme Lead For Spectra Optia
Source: pharmiweb.com